285 related articles for article (PubMed ID: 23229370)
1. The role of the Interleukin 1 receptor-like 1 (ST2) and Interleukin-33 pathway in cardiovascular disease and cardiovascular risk assessment.
Willems S; Hoefer I; Pasterkamp G
Minerva Med; 2012 Dec; 103(6):513-24. PubMed ID: 23229370
[TBL] [Abstract][Full Text] [Related]
2. The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease.
Miller AM; Liew FY
Pharmacol Ther; 2011 Aug; 131(2):179-86. PubMed ID: 21356240
[TBL] [Abstract][Full Text] [Related]
3. The biology of ST2: the International ST2 Consensus Panel.
Pascual-Figal DA; Januzzi JL
Am J Cardiol; 2015 Apr; 115(7 Suppl):3B-7B. PubMed ID: 25665766
[TBL] [Abstract][Full Text] [Related]
4. ST2: a novel biomarker for heart failure.
Bhardwaj A; Januzzi JL
Expert Rev Mol Diagn; 2010 May; 10(4):459-64. PubMed ID: 20465500
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of sST2 in cardiac diseases.
Pascual-Figal DA; Lax A; Perez-Martinez MT; del Carmen Asensio-Lopez M; Sanchez-Mas J;
Clin Chem Lab Med; 2016 Jan; 54(1):29-35. PubMed ID: 26544104
[TBL] [Abstract][Full Text] [Related]
6. ST2 and the ST2/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans.
Pusceddu I; Dieplinger B; Mueller T
Clin Chim Acta; 2019 Aug; 495():493-500. PubMed ID: 31136737
[TBL] [Abstract][Full Text] [Related]
7. The IL-33/ST2 pathway: therapeutic target and novel biomarker.
Kakkar R; Lee RT
Nat Rev Drug Discov; 2008 Oct; 7(10):827-40. PubMed ID: 18827826
[TBL] [Abstract][Full Text] [Related]
8. ST2 as a cardiovascular risk biomarker: from the bench to the bedside.
Januzzi JL
J Cardiovasc Transl Res; 2013 Aug; 6(4):493-500. PubMed ID: 23558647
[TBL] [Abstract][Full Text] [Related]
9. Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction.
Zhang K; Zhang XC; Mi YH; Liu J
Chin Med J (Engl); 2013; 126(19):3628-31. PubMed ID: 24112154
[TBL] [Abstract][Full Text] [Related]
10. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system.
Sanada S; Hakuno D; Higgins LJ; Schreiter ER; McKenzie AN; Lee RT
J Clin Invest; 2007 Jun; 117(6):1538-49. PubMed ID: 17492053
[TBL] [Abstract][Full Text] [Related]
11. Soluble ST2--analytical considerations.
Mueller T; Jaffe AS
Am J Cardiol; 2015 Apr; 115(7 Suppl):8B-21B. PubMed ID: 25697919
[TBL] [Abstract][Full Text] [Related]
12. ST2 and prognosis in acutely decompensated heart failure: the International ST2 Consensus Panel.
Januzzi JL; Mebazaa A; Di Somma S
Am J Cardiol; 2015 Apr; 115(7 Suppl):26B-31B. PubMed ID: 25665762
[TBL] [Abstract][Full Text] [Related]
13. The potential role of IL-33/ST2 signaling in fibrotic diseases.
Gao Q; Li Y; Li M
J Leukoc Biol; 2015 Jul; 98(1):15-22. PubMed ID: 25881899
[TBL] [Abstract][Full Text] [Related]
14. The Presage(®) ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2.
Mueller T; Dieplinger B
Expert Rev Mol Diagn; 2013 Jan; 13(1):13-30. PubMed ID: 23256700
[TBL] [Abstract][Full Text] [Related]
15. Pre-discharge risk stratification in unselected STEMI: is there a role for ST2 or its natural ligand IL-33 when compared with contemporary risk markers?
Dhillon OS; Narayan HK; Khan SQ; Kelly D; Quinn PA; Squire IB; Davies JE; Ng LL
Int J Cardiol; 2013 Sep; 167(5):2182-8. PubMed ID: 22835988
[TBL] [Abstract][Full Text] [Related]
16. Soluble ST2 in heart failure.
Dieplinger B; Mueller T
Clin Chim Acta; 2015 Mar; 443():57-70. PubMed ID: 25269091
[TBL] [Abstract][Full Text] [Related]
17. Soluble ST2 levels are not associated with secondary cardiovascular events and vulnerable plaque phenotype in patients with carotid artery stenosis.
Willems S; Quax PH; de Borst GJ; de Vries JP; Moll FL; de Kleijn DP; Hoefer IE; Pasterkamp G
Atherosclerosis; 2013 Nov; 231(1):48-53. PubMed ID: 24125409
[TBL] [Abstract][Full Text] [Related]
18. A role for soluble ST2 in vascular remodeling associated with obesity in rats.
Martínez-Martínez E; Miana M; Jurado-López R; Rousseau E; Rossignol P; Zannad F; Cachofeiro V; López-Andrés N
PLoS One; 2013; 8(11):e79176. PubMed ID: 24265755
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-33, a novel member of the IL-1/IL-18 cytokine family, in cardiology and cardiac surgery.
Kunes P; Holubcova Z; Kolackova M; Krejsek J
Thorac Cardiovasc Surg; 2010 Dec; 58(8):443-9. PubMed ID: 21113894
[TBL] [Abstract][Full Text] [Related]
20. Temporal changes of soluble ST2 after cardiovascular interventions.
Willems S; Sels JW; Flier S; Versteeg D; Buhre WF; de Kleijn DP; Hoefer IE; Pasterkamp G
Eur J Clin Invest; 2013 Feb; 43(2):113-20. PubMed ID: 23215810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
